Navigation Links
Zeus Partners with Avancen MOD Corp.
Date:2/15/2009

Zeus is slated to manufacture parts and assemble MOD® units, an innovative medication dispenser produced by Avancen MOD Corporation.

Orangeburg, SC (PRWEB) February 15, 2009 -- Zeus, Inc., a global leader in the design and production of high-performance fluoropolymers, is pleased to announce a new partnership with Avancen MOD Corporation. Avancen produces the MOD (Medication on Demand), a wireless device that allows hospitalized patients to directly access their oral pain medication from bedside. Zeus has partnered with the company and will manufacture parts for the MOD and assemble the units.

For more than 40 years, Zeus has been driven by a culture of innovation, problem solving, and customer support to become an internationally recognized leader in the design and production of high-performance polymer extrusions. Multi-national corporations as well as start-up firms look to Zeus for innovative tubing solutions that meet the intense performance requirements of an increasingly specialized world.

Florida-based Avancen will be relocating to North Charleston, South Carolina and Zeus, also headquartered in the State, will be involved in the manufacture and assembly of the MOD. The collaboration will result in technology that ensures prompt delivery of medications, promotes nursing staff efficiency, and improves the general care of hospitalized patients at bedside.

"We are excited about this new partnership with Avancen and welcome the firm to South Carolina," said Bob Ballard, Vice President, Research and Strategic Business Development. "Zeus places a premium on close collaboration with partners, like Avancen, to develop critical processing technologies and process development specific to their applications."

About Zeus, Inc.:
Zeus, Inc. is headquartered in Orangeburg, SC USA. Zeus is a world leader in the design and production of high-performance polymer tubing used in demanding applications; operating multiple facilities in North America and internationally. Zeus products and services are preferred by companies in medical, automotive, electrical, fluid handling, and mechanical markets. For more information, visit www.zeusinc.com.

###

Read the full story at http://www.prweb.com/releases/2009/02/prweb2051134.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Volcano Corporation Presentation at Roth Capital Partners Conference to Be Webcast
2. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
3. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
4. China-Biotics, Inc. to Present at Roth Capital Partners 21st Annual OC Growth Stock Conference
5. Vaccine Against the Chikungunya Virus in Development by a Public-Private Partnership
6. Mirixa Corporation and the APhA Foundation Finalize Partnership
7. PharmaNet Development Group Agrees to be Acquired by JLL Partners
8. BioSpace Partners with Journal of Visualized Experiments (JoVE) to Offer Peer-Reviewed Scientific Video Content on BioSpace.com
9. Fadel Partners Announces 13% Growth Despite IT Services Industry Downtrend
10. University of Glasgow Becomes a Member of GeneGos MetaMiner Stem Cell Partnership Program
11. Jubilant and BioLeap Announce New Partnership in Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: IMLFF), reported today that ... total of 10,672,750 common share purchase warrants have been exercised ... the exercise of these warrants totalled $1,387,458 and 10,672,750 common ... ... expression of confidence by our warrant holders. This infusion of ...
(Date:2/27/2017)... HAMILTON, Bermuda , Feb. 27, 2017 /PRNewswire/ ... ) and SELLAS Life Sciences Group , ... immunotherapies, today announced that Advaxis has granted SELLAS ... agent using Advaxis, proprietary Lm -based antigen ... peptide antigen mixture (galinpepimut-S). Advaxis, ...
(Date:2/27/2017)... , ... February 27, 2017 , ... The Catalyst ... a few in the Midwest offering premix services and private label organic services. , ... laying hens, according Jos Zamzow, chief operating officer of Dynamite Marketing, which owns the ...
(Date:2/24/2017)... MA (PRWEB) , ... February 24, 2017 , ... ... replacement (TDR) procedures can be safely completed in an ambulatory surgery center (ASC) ... fusion (ACDF) procedures and previous two-year TDR studies. , Jake Lubinski, president ...
Breaking Biology Technology:
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:2/1/2017)... 2017 IDTechEx Research, a leading provider of ... the availability of a new report, Sensors for Robotics: Technologies, ... Reading ... ... Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets and Forecasts 2017-2027: ...
(Date:1/26/2017)... PANAMA CITY , Jan. 26, 2017  Crossmatch, ... today unveiled a new solution aimed at combatting fraud, ... The solution was introduced at the Action on Disaster ... a key meeting point for UN agencies and foreign ... Fraud, waste and abuse are a largely ...
Breaking Biology News(10 mins):